(Q39444553)

12 September 2017

title

Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer (English)

1 reference

12 September 2017

Jin Cheon Kim

1

1 reference

12 September 2017

Jong Han Yu

2

1 reference

12 September 2017

Yoon Kyung Cho

3

1 reference

12 September 2017

Choon Sik Jung

4

1 reference

12 September 2017

Sei Hyun Ahn

5

1 reference

12 September 2017

Gyungyub Gong

6

1 reference

12 September 2017

Yong Sung Kim

7

1 reference

12 September 2017

Dong-Hyung Cho

8

1 reference

12 September 2017

language of work or name

English

0 references

publication date

11 November 2011

1 reference

Breast Cancer Research and Treatment

12 September 2017

published in

1 reference

12 September 2017

volume

133

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

909-916

1 reference

Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10 years (1996-2006) using nationwide breast cancer registration on-line program: biannual update.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Cancer burden in the year 2000. The global picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

p53 and breast cancer, an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

A small proline-rich protein, SPRR1, is upregulated early during tobacco smoke-induced squamous metaplasia in rat nasal epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Gene expression profiling: canonical molecular changes and clinicopathological features in sporadic colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Reporting recommendations for tumor marker prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Biology of HER2 and its importance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Triple negative breast cancer: unmet medical needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Akt enhances Mdm2-mediated ubiquitination and degradation of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1868-5

10.1007/S10549-011-1868-5

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference